Literature DB >> 8098726

Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma.

S F Radka1, S Nakamura, S Sakurada, S Z Salahuddin.   

Abstract

Oncostatin M (OM), a 30-kDa glycoprotein, recently was identified as a major growth-promoting factor in the conditioned medium (CM) of the 38-0 cell line, a CD4,+ chronically human T lymphotropic virus type (HTLV)-II-infected, transformed T cell line. CM 38-0 induced the proliferation of spindle cells cultured in vitro from AIDS-associated Kaposi's sarcoma (AIDS-KS) cells. To determine how much of the AIDS-KS cell growth activity present in 38-0 CM was because of the presence of OM, we depleted OM by using specific mAb-affinity chromatography. OM purified from this CM stimulated AIDS-KS cell growth in a concentration-dependent fashion. The effluent, completely depleted of OM, failed to induce growth of AIDS-KS cells. To detect the constitutive release of OM by cells acutely or chronically infected with either HTLV-I, HTLV-II, or HIV-1, we utilized an enzyme-linked immunoassay. Whereas the chronically infected cells released significant levels of OM, the acutely infected cells released little or no OM. The presence of OM in HIV-1-infected T-cell CM correlated completely with AIDS-KS cell growth activity. Infrequently, low level AIDS-KS cell growth activity was seen in the absence of OM. This correlated with relatively high levels of IL-6 in the CM. In a CM-containing OM in the absence of detectable IL-6, a neutralizing antibody to OM completely abrogated KS cell growth activity. The presence of specific oncostatin M receptors on the KS cell lines was confirmed by cross-linking experiments. The results shown here suggest that T cells chronically infected with HIV-1 can secrete OM, which may play a role in the initiation or progression of AIDS-KS lesions, either alone, or in concert with IL-6.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098726

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Myocardial healing requires Reg3β-dependent accumulation of macrophages in the ischemic heart.

Authors:  Holger Lörchner; Jochen Pöling; Praveen Gajawada; Yunlong Hou; Viktoria Polyakova; Sawa Kostin; Juan M Adrian-Segarra; Thomas Boettger; Astrid Wietelmann; Henning Warnecke; Manfred Richter; Thomas Kubin; Thomas Braun
Journal:  Nat Med       Date:  2015-03-09       Impact factor: 53.440

2.  Human herpesvirus 8 encodes a homolog of interleukin-6.

Authors:  F Neipel; J C Albrecht; A Ensser; Y Q Huang; J J Li; A E Friedman-Kien; B Fleckenstein
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  A possible role of multidrug resistance-associated protein (MRP) in basic fibroblast growth factor secretion by AIDS-associated Kaposi's sarcoma cells: a survival molecule?

Authors:  S Gupta; S Aggarwal; S Nakamura
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

4.  Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia.

Authors:  Pavle Repovic; Etty N Benveniste
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

5.  AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.

Authors:  K Murakami-Mori; T Taga; T Kishimoto; S Nakamura
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Involvement of vascular endothelial growth factor in Kaposi's sarcoma associated with acquired immunodeficiency syndrome.

Authors:  S Sakurada; T Kato; K Mashiba; S Mori; T Okamoto
Journal:  Jpn J Cancer Res       Date:  1996-11

7.  Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication.

Authors:  Mi-Kyung Park; Hyejeong Cho; Seong Woon Roh; Seong-Jun Kim; Jinjong Myoung
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

8.  Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu mice.

Authors:  P J Browning; D D Roberts; V Zabrenetzky; J Bryant; M Kaplan; R H Washington; A Panet; R C Gallo; T Vogel
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.